Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dare Bioscience (DARE) Depreciation & Amortization (CF) (2016 - 2025)

Dare Bioscience (DARE) has disclosed Depreciation & Amortization (CF) for 11 consecutive years, with $481906.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Depreciation & Amortization (CF) rose 4846.68% year-over-year to $481906.0, compared with a TTM value of $1.1 million through Sep 2025, up 2308.64%, and an annual FY2024 reading of $42325.0, up 10.33% over the prior year.
  • Depreciation & Amortization (CF) was $481906.0 for Q3 2025 at Dare Bioscience, up from $460075.0 in the prior quarter.
  • Across five years, Depreciation & Amortization (CF) topped out at $481906.0 in Q3 2025 and bottomed at $3034.0 in Q3 2022.
  • Average Depreciation & Amortization (CF) over 5 years is $64810.2, with a median of $9508.0 recorded in 2023.
  • The sharpest move saw Depreciation & Amortization (CF) tumbled 52.17% in 2022, then skyrocketed 4846.68% in 2025.
  • Year by year, Depreciation & Amortization (CF) stood at $7047.0 in 2021, then skyrocketed by 50.73% to $10622.0 in 2022, then decreased by 6.04% to $9980.0 in 2023, then crashed by 36.19% to $6368.0 in 2024, then skyrocketed by 7467.62% to $481906.0 in 2025.
  • Business Quant data shows Depreciation & Amortization (CF) for DARE at $481906.0 in Q3 2025, $460075.0 in Q2 2025, and $158110.0 in Q1 2025.